Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study

NCT07254208 is registered in ClinicalTrials.gov with Precision BioSciences, Inc. as lead sponsor.

NCT NCT07254208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07254208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study
Lead sponsor
Precision BioSciences, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 25, 2025
Completion date
June 30, 2040
Enrollment
45 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hbv infection